Motivation Psychology-based Smart Engagement System
MOSES
1 other identifier
interventional
88
1 country
1
Brief Summary
In 2010, 25.8 million people in the US, or 8.3% of the population were reported to have diabetes. Type 2 diabetes mellitus (T2DM) is especially prevalent among older adults: 26.9% of people 65 years or older have diabetes with 50% being pre-diabetic. Diabetes is the leading cause of blindness, kidney disease and lower-limb amputation among older adults, and is also a major risk factor for cardiovascular disease. Fortunately, diabetes and its related complications are very amenable to lifestyle changes. Engagement with healthcare providers can significantly affects behavior and disease management of practices of individuals as does social engagement. The use of mobile technology and better engagement with providers and peer support networks may support diabetes self-care management. Individual patient personality attributes may affect the success of technology interventions. In this study, the investigators propose to design and test a motivation psychology-based smart engagement system (MOSES), which is a software application on a digital tablet device. The pre-loaded tablets will be provided to adults with T2DM (age 60+ with high glucose). The software will allow the patients to record diabetes self-care activities (exercise, glucose, nutrition, medication adherence), pursue goals, support communication between the patient and a health coach, support communication between peer patients, and visualize health status more easily by patients and providers. This research program will enroll 88 patients (4 intervention groups of 12 persons each and a 40-person control group) in a 90-day pilot study to test and refine the design of the application and its effectiveness in supporting care plan goals. Primary Aim 1: Design, implement, and optimize a motivation psychology-based smart engagement system (MOSES) for older adults with diabetes. Secondary Aim 2: Determine if providing older adult diabetic patients to care managers and peers via a digital tablet-based software application leads to improved diabetes management as measured by blood glucose control. Secondary Aim 3: Refine the personality attributes used to tailor the interaction with the application.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes
Started Jun 2014
Longer than P75 for not_applicable diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 29, 2014
CompletedFirst Posted
Study publicly available on registry
April 30, 2014
CompletedStudy Start
First participant enrolled
June 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedJuly 14, 2020
July 1, 2020
7.9 years
April 29, 2014
July 10, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement in hemoglobin A1c
3 months
Secondary Outcomes (1)
Adherence to diabetes care plan
3 months
Study Arms (5)
Standard of Care Group - A
NO INTERVENTIONThe control group
MOSES - Group B
ACTIVE COMPARATORIndividual patients using application and pedometer without healthcare provider support
MOSES - Group C
ACTIVE COMPARATORIndividual patients using application and pedometer with healthcare provider support
MOSES - Group D
ACTIVE COMPARATORPeer patient teams using application and pedometer without healthcare provider support
MOSES - Group E
ACTIVE COMPARATORPeer patient teams using application and pedometer with healthcare provider support
Interventions
MOSES is an integrated system between a patient, peer patients, and healthcare providers.
Eligibility Criteria
You may qualify if:
- Veterans 60 years of age and older with an HbA1c of \>7.9%
- Recieving routine medical care within the University of Maryland Medical Center Midtown Campus (UMMCMC) who are 60 years of age and older with HbA1c of \>7.9%
You may not qualify if:
- Unable to provide informed consent
- Blindness
- Deaf
- Type I DM
- Active Serious Mental Illness
- Homelessness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baltimore VA Maryland Health Care System
Baltimore, Maryland, 21201, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nanette Steinle, MD
Baltimore VA Maryland Health Care System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2014
First Posted
April 30, 2014
Study Start
June 1, 2014
Primary Completion
May 1, 2022
Study Completion
June 1, 2022
Last Updated
July 14, 2020
Record last verified: 2020-07